KRAS and androgen insensitivity syndrome: Several important players such as K-ras, p53, and survivin, etc. have been considered as tumor markers in AIS progression into invasive cancer[16-18,25], few are specific to AIS and “driver mutations” for AIS progression are still unidentified.